Dutasteride Prior to Contrast-Enhanced Colour Doppler Ultrasound Prostate Biopsy Increases Prostate Cancer Detection

European Urology

Volumn 53, Issue 1, 2008, Pages 112-117

  Mitterberger, Michael ^a   Pinggera, Germar ^a   Horninger, Wolfgang ^a   Strasser, Hannes ^a   Halpern, Ethan ^b   Pallwein, Leo ^a   Gradl, Johann ^a   Bartsch, Georg ^a   Frauscher, Ferdinand ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Contrast enhanced colour Doppler ultrasound; Dutasteride; Prostate biopsy

Indexed keywords

DUTASTERIDE; PROSTATE SPECIFIC ANTIGEN; SONOVUE;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

ADMINISTRATION, ORAL; ADULT; AGED; AZASTEROIDS; BIOPSY; BLOOD FLOW VELOCITY; CONTRAST MEDIA; ENDOSONOGRAPHY; ENZYME INHIBITORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TESTOSTERONE 5-ALPHA-REDUCTASE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 36448988245     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.02.031     Document Type: Article

References (15)

1. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
2. Aarnink R.G., Beerlage H.P., De La Rosette J.J., Debruyne F.M., and Wijkstra H. Transrectal ultrasound of the prostate: innovations and future applications. J Urol 159 (1998) 1568-1579
3. Kravchick S., Cytron S., Peled R., Altshuler A., and Ben-Dor D. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology 61 (2003) 977-981
4. Frauscher F., Klauser A., Volgger H., et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167 (2002) 1648-1652
5. Pelzer A., Bektic J., Berger A.P., et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173 (2005) 1926-1929
6. Donohue J.F., Sharma H., Abraham R., Natalwala S., Thomas D.R., and Foster M.C. Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss. J Urol 168 (2002) 2024-2026
7. Hochberg D.A., Basillote J.B., Armenakas N.A., et al. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia. J Urol 167 (2002) 1731-1733
8. Leventis A.K., Shariat S.F., Utsunomiya T., and Slawin K.M. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 46 (2001) 281-288
9. Ives E.P., Gomella L.G., and Halpern E.J. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results. Radiology 237 (2005) 197-201
10. Halpern E.J., McCue P.A., Aksnes A.K., Hagen E.K., Frauscher F., and Gomella L.G. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 222 (2002) 361-366
11. van Moerkerk H., Heijmink S.W., Hulsbergen-v.d. Kaa C.A., Barentsz J.O., and Witjes J.A. Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis. Eur Urol 50 (2006) 762-768 discussion 768-9
12. Halpern E.J., Rosenberg M., and Gomella L.G. Prostate cancer: contrast-enhanced US for detection. Radiology 219 (2001) 219-225
13. Hamper U.M., Sheth S., Walsh P.C., Holtz P.M., and Epstein J.I. Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions. Radiology 180 (1991) 101-104
14. Halpern E.J., Ramey J.R., Strup S.E., Frauscher F., McCue P., and Gomella L.G. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104 (2005) 2373-2383
15. Pelzer A.E., Bektic J., Berger A.P., et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol Screening Project. Eur Urol 48 (2005) 916-921 discussion 921